Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dGuvCrsecruJsmBJtKvZ?format=wireless

  ADVERTISEMENT  
June 9, 2012
  ADVERTISEMENT  
News for diabetes health professionals
Sign up|Forward|Archive|Advertise

ADA Scientific Sessions 
  • TODAY trial results are the focus of symposium
    Key findings and interpretations from the NIH-sponsored TODAY (Treatment Options for Type 2 Diabetes in Adolescents and Youth) trial are the focus of a Saturday symposium. Primary glycemic outcomes of the trial, which was aimed at helping identify more optimal treatment approaches, have been published, but findings related to beta cell function, treatment-related adverse events, comorbidities and other factors are being discussed publicly for the first time. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Research examines environmental, genetic links to diabetic kidney disease
    Identifying environmental and genetic factors of diabetic kidney disease may help practitioners treat and prevent the disease, researchers said at the ADA Scientific Sessions. "If we can identify gene variants that confer susceptibility to diabetic kidney disease, they may help us manage and treat this disease more effectively," says Dr. John R. Sedor, MetroHealth Research Endowment Professor and Case Western Reserve University School of Medicine vice president. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Researchers discuss promise of beta cell proliferation
    Research into ways to manipulate beta cell proliferation to reduce the need for insulin has produced a mass of information that presents conflicting findings and will be the subject of the symposium "Beta Cell Origins and Proliferation in Mice and Humans." While research supports the proliferation and regeneration of cells in mice, direct evidence of similar outcomes for humans has yet to surface. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Study shows impact of inactivity for diabetes patients
    Sedentary behavior may have as vital an impact on the health of diabetes patients as poor glycemic control, presenters at a symposium on physical activity said. Inactivity is a key element in the development of skeletal muscle insulin resistance and impaired glycemic control, according to study results presented by University of Missouri-Columbia Associate Professor John Thyfault. He said a single bout of activity for normally sedentary diabetes patients can improve blood glucose control for an entire day. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Symposium reviews animal research on impaired brain insulin signaling
    High insulin levels -- triggered by pancreatic beta cells producing insulin in response to insulin resistance in diabetes -- can impact lipid metabolism, life span and fertility, according to animal research presented at the symposium "Insulin Action via the Brain." One of the studies under discussion focused on the fertility effects of manipulating insulin receptors in female mice fed a high-fat diet. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Behavioral intervention helps diabetes patients with chronic conditions
    Behavioral interventions are a proven treatment strategy for helping diabetes patients cope with eating disorders, depression, anxiety and other chronic health conditions, researchers will discuss today at the session, "Behavioral Interventions in Routine Clinical Care -- What Works?" "Ninety percent of patients with diabetes have at least one other chronic condition. The care involved in managing chronic conditions is complex. Add to that the common challenges of daily living and patients can be overwhelmed, which can lead to or exacerbate depression and anxiety," said Dr. Paul Ciechanowski of the University of Washington in Seattle. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Presenters discuss factors impacting insulin resistance
    Presenters at the Friday symposium "Mechanisms of Insulin Resistance in Humans -- Inflammations and Lipids" sought to clarify some of the ways in which diet, exercise and lipids contribute to insulin resistance. The location in which bodies store lipids, for example, can impact clinical outcomes for diabetes patients. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Experts look at methods to combat hypoglycemia unawareness
    Methods to combat hypoglycemia unawareness and manage severe hypoglycemia are the subject of the symposium "Beta Cell Replacement Therapies for Severe Hypoglycemia and Hypoglycemia Unawareness." Experts will discuss islet cell and pancreas transplants and medical therapies for patients with hypoglycemia. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Latest diabetic nephropathy findings examined in symposium
    Presenters are discussing the latest research on the pathogenesis of and treatments for diabetic nephropathy as part of the Saturday session "The Holy Grail of Advancing Therapeutics for Diabetic Kidney Disease." One expert will offer evidence on the possible causative role of oxidative stress and inflammation in the development of diabetic kidney disease. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  • Studies show elevated cardiovascular risks for women with diabetes
    The afternoon symposium "Women, Diabetes, and Cardiovascular Disease -- The Perfect Storm" will look at the growing body of medical evidence showing that women with diabetes face more cardiovascular disease risks than men. Experts also will discuss research showing that women with gestational diabetes or pregnancy-related complications may have higher cardiovascular disease risks later in life. ADA Diabetes Dispatch (2012) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Support DiabetesPro SmartBrief
DiabetesPro SmartBrief is the daily e-news resource for 29,000 influential leaders in diabetes care. E-mail Aaron Kern for more information on advertising.

Conference Information 
  • Networking reception
    Join us in the Grand Hall at the Pennsylvania Convention Center today from 6:15 p.m. to 7:30 p.m. for a Networking Reception. Exchange ideas or informally share best practices with your colleagues in a relaxing atmosphere. Light hors d'oeuvres and beverages will be provided. LinkedInFacebookTwitterEmail this Story
  • Wear red tomorrow (Sunday)
    Support ADA's movement to Stop Diabetes by wearing red. Have you joined the millions? LinkedInFacebookTwitterEmail this Story
  • 5K@ADA Tomorrow
    The Run/Walk, supported by Novo Nordisk, will be held on Sunday, June 10, at 6:30 a.m. The scenic course will take you through Philadelphia's historic and scenic Fairmount Park. The event is free of charge to all registered Scientific Sessions attendees. Race in style sporting a 5K@ADA running shirt, available for a $20 donation to ADA's Research Foundation. Purchase your running shirt and sign up for the Fun Run/Walk in the registration area. LinkedInFacebookTwitterEmail this Story
  • Meeting updates and highlights
    The 72nd Scientific Sessions website will include a page listing program updates and changes as they happen. The page will also include daily meeting highlights and events. Learn more. LinkedInFacebookTwitterEmail this Story
  • Get the 72nd Scientific Sessions App!
    Planning your time at the Scientific Sessions is only a click away with the on-the-go Scientific Sessions App! This application gives direct and instant access to meeting information from your smartphone, tablet or other handheld device. Features include interactive program and course schedules, customizable calendar and itinerary builder, exhibitor listing with interactive booth map, social media interaction and special meeting alerts. Learn more. LinkedInFacebookTwitterEmail this Story
  • Diabetes Dispatch Newspaper
    Read the full newspaper of the 72nd Scientific Sessions to learn about what's happening at the meeting this year. Read it now. LinkedInFacebookTwitterEmail this Story
  

Product announcements appearing in SmartBrief are paid advertisements and do not reflect actual DiabetesPro endorsements. The news reported in SmartBrief does not necessarily reflect the official position of DiabetesPro.
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Advertise
Account Director: Aaron Kern (202) 407-7866
 
Read more at SmartBrief.com
 
 
 Recent DiabetesPro SmartBrief Issues:   Editor: Kathryn Doherty

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2014 SmartBrief, Inc.® Legal Information